Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain

2016 ◽  
Vol 4 (6) ◽  
pp. 567-575 ◽  
Author(s):  
Iván Castilla-Rodríguez ◽  
Elena Cela ◽  
Laura Vallejo-Torres ◽  
Cristina Valcárcel-Nazco ◽  
Elena Dulín ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Sickle Cell Disease ◽  
Newborn Screening ◽  
Sickle Cell ◽  
Cost Effectiveness Analysis ◽  
Cell Disease ◽  
Effectiveness Analysis

Neonatal screening for sickle cell disease: A cost-effectiveness analysis

1991 ◽  
Vol 118 (4) ◽  
pp. 546-554 ◽  
Author(s):  
Joel Tsevat ◽  
John B. Wong ◽  
Stephen G. Pauker ◽  
Martin H. Steinberg
Keyword(s):  
Cost Effectiveness ◽  
Sickle Cell Disease ◽  
Sickle Cell ◽  
Neonatal Screening ◽  
Cost Effectiveness Analysis ◽  
Cell Disease ◽  
Effectiveness Analysis

Hydroxyurea use in prevention of stroke recurrence in children with sickle cell disease in a developing country: A cost effectiveness analysis

2015 ◽  
Vol 62 (10) ◽  
pp. 1862-1864 ◽  
Author(s):  
Colette Cunningham-Myrie ◽  
Abdullahi Abdulkadri ◽  
Andre Waugh ◽  
Susanna Bortolusso Ali ◽  
Lesley-Gaye King ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Sickle Cell Disease ◽  
Developing Country ◽  
Sickle Cell ◽  
Cost Effectiveness Analysis ◽  
Stroke Recurrence ◽  
Cell Disease ◽  
Effectiveness Analysis

scholarly journals Cost-effectiveness analysis of preoperative transfusion in patients with sickle cell disease using evidence from the TAPS trial

2013 ◽  
Vol 92 (3) ◽  
pp. 249-255 ◽  
Author(s):  
Eldon Spackman ◽  
Mark Sculpher ◽  
Jo Howard ◽  
Moira Malfroy ◽  
Charlotte Llewelyn ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Sickle Cell Disease ◽  
Sickle Cell ◽  
Cost Effectiveness Analysis ◽  
Cell Disease ◽  
Effectiveness Analysis
Sign in / Sign up

Export Citation Format

Share Document